A 2-Month Safety Follow-Up Trial
NCT00741429
·
clinicaltrials.gov ↗
COMPLETED
Status
649
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes
Type 2 Diabetes
Interventions
DRUG:
Technosphere Insulin Inhalation Powder
DRUG:
Comparator
Sponsor
Mannkind Corporation